Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 High Potency Active Pharmaceutical Ingredients (APIs) Industry
Figure High Potency Active Pharmaceutical Ingredients (APIs) Industry Chain Structure
1.1.1 Overview
1.1.2 Development of High Potency Active Pharmaceutical Ingredients (APIs)
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of High Potency Active Pharmaceutical Ingredients (APIs)
1.2.2 Downstream
Table Application Segment of High Potency Active Pharmaceutical Ingredients (APIs)
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 High Potency Active Pharmaceutical Ingredients (APIs) Market by Type
3.1 By Type
3.1.1 Synthetic
Table Major Company List of Synthetic
3.1.2 Biotech
Table Major Company List of Biotech
3.2 Market Size
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2016-2020, by Type, in USD Million
Figure Global High Potency Active Pharmaceutical Ingredients (APIs) Market Growth 2016-2020, by Type, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2016-2020, by Type, in Volume
Figure Global High Potency Active Pharmaceutical Ingredients (APIs) Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2021-2026, by Type, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Lonza (Company Profile, Sales Data etc.)
4.1.1 Lonza Profile
Table Lonza Overview List
4.1.2 Lonza Products & Services
4.1.3 Lonza Business Operation Conditions
Table Business Operation of Lonza (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Novartis International AG (Company Profile, Sales Data etc.)
4.2.1 Novartis International AG Profile
Table Novartis International AG Overview List
4.2.2 Novartis International AG Products & Services
4.2.3 Novartis International AG Business Operation Conditions
Table Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 BASF AG (Company Profile, Sales Data etc.)
4.3.1 BASF AG Profile
Table BASF AG Overview List
4.3.2 BASF AG Products & Services
4.3.3 BASF AG Business Operation Conditions
Table Business Operation of BASF AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Carbogen Amcis AG (Company Profile, Sales Data etc.)
4.4.1 Carbogen Amcis AG Profile
Table Carbogen Amcis AG Overview List
4.4.2 Carbogen Amcis AG Products & Services
4.4.3 Carbogen Amcis AG Business Operation Conditions
Table Business Operation of Carbogen Amcis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Eli Lilly and Company (Company Profile, Sales Data etc.)
4.5.1 Eli Lilly and Company Profile
Table Eli Lilly and Company Overview List
4.5.2 Eli Lilly and Company Products & Services
4.5.3 Eli Lilly and Company Business Operation Conditions
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)
4.6.1 Teva Pharmaceutical Industries Ltd Profile
Table Teva Pharmaceutical Industries Ltd Overview List
4.6.2 Teva Pharmaceutical Industries Ltd Products & Services
4.6.3 Teva Pharmaceutical Industries Ltd Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
4.7.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
4.7.2 Bristol-Myers Squibb Products & Services
4.7.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Pfizer Inc. (Company Profile, Sales Data etc.)
4.8.1 Pfizer Inc. Profile
Table Pfizer Inc. Overview List
4.8.2 Pfizer Inc. Products & Services
4.8.3 Pfizer Inc. Business Operation Conditions
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Roche Diagnostics. (Company Profile, Sales Data etc.)
4.9.1 Roche Diagnostics. Profile
Table Roche Diagnostics. Overview List
4.9.2 Roche Diagnostics. Products & Services
4.9.3 Roche Diagnostics. Business Operation Conditions
Table Business Operation of Roche Diagnostics. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Hospira Inc (Company Profile, Sales Data etc.)
4.10.1 Hospira Inc Profile
Table Hospira Inc Overview List
4.10.2 Hospira Inc Products & Services
4.10.3 Hospira Inc Business Operation Conditions
Table Business Operation of Hospira Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.11.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.11.2 Boehringer Ingelheim Products & Services
4.11.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Covidien Plc (Company Profile, Sales Data etc.)
4.12.1 Covidien Plc Profile
Table Covidien Plc Overview List
4.12.2 Covidien Plc Products & Services
4.12.3 Covidien Plc Business Operation Conditions
Table Business Operation of Covidien Plc (Sales Revenue, Cost, Gross Margin)
4.13 Merck & Co (Company Profile, Sales Data etc.)
4.13.1 Merck & Co Profile
Table Merck & Co Overview List
4.13.2 Merck & Co Products & Services
4.13.3 Merck & Co Business Operation Conditions
Table Business Operation of Merck & Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Bayer AG (Company Profile, Sales Data etc.)
4.14.1 Bayer AG Profile
Table Bayer AG Overview List
4.14.2 Bayer AG Products & Services
4.14.3 Bayer AG Business Operation Conditions
Table Business Operation of Bayer AG (Sales Revenue, Cost, Gross Margin)
4.15 Sigma-Aldrich Corporation (Company Profile, Sales Data etc.)
4.15.1 Sigma-Aldrich Corporation Profile
Table Sigma-Aldrich Corporation Overview List
4.15.2 Sigma-Aldrich Corporation Products & Services
4.15.3 Sigma-Aldrich Corporation Business Operation Conditions
Table Business Operation of Sigma-Aldrich Corporation (Sales Revenue, Cost, Gross Margin)
4.16 Sanofi Aventis (Company Profile, Sales Data etc.)
4.16.1 Sanofi Aventis Profile
Table Sanofi Aventis Overview List
4.16.2 Sanofi Aventis Products & Services
4.16.3 Sanofi Aventis Business Operation Conditions
Table Business Operation of Sanofi Aventis (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Revenue 2016-2020, by Company, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Revenue Share in 2020, by Company, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Volume 2016-2020, by Company, in Volume
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Volume Share 2016-2020, by Company, in Volume
Figure Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America High Potency Active Pharmaceutical Ingredients (APIs) Market Concentration, in 2020
Figure Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Market Concentration, in 2020
Figure Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) MMarket Concentration, in 2020
Figure South America High Potency Active Pharmaceutical Ingredients (APIs) Market Concentration, in 2020
Figure Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Oncology
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Oncology, 2016-2020, in USD Million
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Oncology, 2016-2020, in Volume
6.1.2 Demand in Hormonal
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Hormonal, 2016-2020, in USD Million
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Hormonal, 2016-2020, in Volume
6.1.3 Demand in Glaucoma
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Glaucoma, 2016-2020, in USD Million
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Glaucoma, 2016-2020, in Volume
6.1.4 Demand in Others
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Others, 2016-2020, in USD Million
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table High Potency Active Pharmaceutical Ingredients (APIs) Demand Forecast 2021-2026, by Application, in USD Million
Figure High Potency Active Pharmaceutical Ingredients (APIs) Market Growth 2021-2026, by Application, in USD Million
Figure High Potency Active Pharmaceutical Ingredients (APIs) Market Share in 2026, by Application, in USD Million
Table High Potency Active Pharmaceutical Ingredients (APIs) Demand Forecast 2021-2026, by Application, in Volume
Table High Potency Active Pharmaceutical Ingredients (APIs) Market Growth 2021-2026, by Application, in Volume
Table High Potency Active Pharmaceutical Ingredients (APIs) Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table High Potency Active Pharmaceutical Ingredients (APIs) Production 2016-2020, by Region, in USD Million
Table High Potency Active Pharmaceutical Ingredients (APIs) Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2016-2020, by Region, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Share 2016-2020, by Region, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2016-2020, by Region, in Volume
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2016-2020, in USD Million
Figure North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in USD Million
Table North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2016-2020, in USD Million
Figure Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in USD Million
Table Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2016-2020, in USD Million
Figure South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in USD Million
Table South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2021-2026, by Region, in USD Million
Table High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of High Potency Active Pharmaceutical Ingredients (APIs)
2. Table Application Segment of High Potency Active Pharmaceutical Ingredients (APIs)
3. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Biotech
5. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2016-2020, by Type, in USD Million
6. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2016-2020, by Type, in Volume
7. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2021-2026, by Type, in USD Million
8. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2021-2026, by Type, in Volume
9. Table Lonza Overview List
10. Table Business Operation of Lonza (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
11. Table Novartis International AG Overview List
12. Table Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table BASF AG Overview List
14. Table Business Operation of BASF AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Carbogen Amcis AG Overview List
16. Table Business Operation of Carbogen Amcis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Eli Lilly and Company Overview List
18. Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Teva Pharmaceutical Industries Ltd Overview List
20. Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Bristol-Myers Squibb Overview List
22. Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Pfizer Inc. Overview List
24. Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Roche Diagnostics. Overview List
26. Table Business Operation of Roche Diagnostics. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Hospira Inc Overview List
28. Table Business Operation of Hospira Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Boehringer Ingelheim Overview List
30. Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table Covidien Plc Overview List
32. Table Business Operation of Covidien Plc (Sales Revenue, Cost, Gross Margin)
33. Table Merck & Co Overview List
34. Table Business Operation of Merck & Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
35. Table Bayer AG Overview List
36. Table Business Operation of Bayer AG (Sales Revenue, Cost, Gross Margin)
37. Table Sigma-Aldrich Corporation Overview List
38. Table Business Operation of Sigma-Aldrich Corporation (Sales Revenue, Cost, Gross Margin)
39. Table Sanofi Aventis Overview List
40. Table Business Operation of Sanofi Aventis (Sales Revenue, Cost, Gross Margin)
41. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Revenue 2016-2020, by Company, in USD Million
42. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Revenue Share 2016-2020, by Company, in USD Million
43. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Volume 2016-2020, by Company, in Volume
44. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Volume Share 2016-2020, by Company, in Volume
45. Table Regional Demand Comparison List
46. Table Major Application in Different Regions
47. Table High Potency Active Pharmaceutical Ingredients (APIs) Demand Forecast 2021-2026, by Application, in USD Million
48. Table High Potency Active Pharmaceutical Ingredients (APIs) Demand Forecast 2021-2026, by Application, in Volume
49. Table High Potency Active Pharmaceutical Ingredients (APIs) Market Growth 2021-2026, by Application, in Volume
50. Table High Potency Active Pharmaceutical Ingredients (APIs) Market Share in 2026, by Application, in Volume
51. Table High Potency Active Pharmaceutical Ingredients (APIs) Production 2016-2020, by Region, in USD Million
52. Table High Potency Active Pharmaceutical Ingredients (APIs) Production 2016-2020, by Region, in Volume
53. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2016-2020, by Region, in USD Million
54. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Share 2016-2020, by Region, in USD Million
55. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2016-2020, by Region, in Volume
56. Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Share 2016-2020, by Region, in Volume
57. Table North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in USD Million
58. Table North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in Volume
59. Table Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in USD Million
60. Table Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in Volume
61. Table Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in USD Million
62. Table Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in Volume
63. Table South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in USD Million
64. Table South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in Volume
65. Table Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in USD Million
66. Table Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2016-2020, by Country, in Volume
67. Table High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2021-2026, by Region, in USD Million
68. Table High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2021-2026, by Region, in Volume
69. Table Price Factors List